Healthcare-associated infections (hai) program

​​Antimicrobial Resistance (AR) Webinars

Data & Reporting ​​

  • C. auris Reporting, Surveillance, and Lab Testing – 11/9/22​
  • ​Carbapenemase-producing Organisms (CPOs): Guidance for Reporting and Containment –​ 9/29/22
  • ​AR Testing: Public Health Laboratory Testing Updates, and Recommendations  for Isolate Submission and Reporting –​ ​10/6/21​
​Laboratory​​​ Testing​​

AR Testing ​

  • AR Testing: Public Health Laboratory Testing Updates, and Recommendations for Isolate Submission and Reporting –​ ​10/6/21​​

C. auris Testing ​

  • Admission Screening for C. auris in Acute Care Hospitals – 1/23/24
  • ​​​C. auris Reporting, Surveillance, and Lab Testing –​ 11/9/22
  • ​​​Finding C. auris in CA Clinical Labs: Strategies That Work for Us! –​​ 5/19/22

Carbapenemase Testing

  • CPOs: CDPH Laboratory and Epidemiology Updates – 5/14/24​​​
  • The Role of Carbapenemase Testing in Clinical Practice –​ 12/6/22
  • Testing for Carbapenemase Production Among Carbapenem-resistant Organisms: When and How? –    10/27/22

Prevention​​ & Response

  • ​​​Best Practices for SNFs in Accepting Residents with MDROs – 2/15/24
  • Admission Screening for C. auris in Acute Care Hospitals – 1/23/24
  • Carbapenemase-producing Organisms (CPOs): Guidance for Reporting and Containment – 9/29/22
  • CDC Simplifying Carbapenem-resistant Organisms – 2022 
  • C. auris ​and other novel MDRO prevention in LTCFs –​ 12/10/20

​Find Additional CDPH Resources​

Page Last Updated :